NDC Pharmacologic Class N0000182634 CTLA-4-directed Antibody Interactions [MoA]

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
0003-2327Yervoy IpilimumabInjectionIntravenousE.r. Squibb & Sons, L.l.c.Human Prescription Drug
0003-2328Yervoy IpilimumabInjectionIntravenousE.r. Squibb & Sons, L.l.c.Human Prescription Drug

There are 2 NDC products with the pharmacologic class CTLA-4-directed Antibody Interactions [MoA].